Start by Topic

11 research hubs

A Large Target-Price Gap Is Not Enough: KB Financial and Hana Financial Screen Best

A proprietary Korea Top 100 screen combining two-month Naver consensus target-price gaps, target revisions, foreign plus real-money flow, and 20/50-day trend position. KB Financial and Hana Financial are the only comfortable entries. Samsung Biologics is a watch item, while Hanwha Aerospace, Samyang Foods, and Alteogen need confirmation.

Hyundai E&C and Woojin: Where Is the Asymmetric Bargaining Power in U.S. Nuclear Expansion?

A follow-up framework on Korea's U.S. nuclear opportunity. Hyundai E&C has the more direct U.S. execution exposure through Fermi AP1000 and Holtec SMR-300. Woojin has the smaller but more asymmetric instrumentation option. The key gates are Hyundai's contract structure and Woojin's still-unverified AP1000 adoption.

Korean Semiconductor Top 50: Which Names Can Beat Samsung and SK Hynix Over the Next Two Months?

A proprietary Thesis OS screen combining 1,137 Naver ETF constituent scans and local investor-flow data to identify Korean semiconductor second-line equipment, substrate, inspection and AI storage candidates that could outperform Samsung Electronics and SK Hynix over the next two months.

Midway Through June's Event Cluster: This Was a Rates, Oil, and AI Crowding Stress Test

A review of the first half of June: U.S. jobs, CPI, PPI, Jensen Huang's Korea visit, the SpaceX IPO, foreign selling in Korean memory stocks, and the June 12 rebound. The conclusion is not easing confirmation, but a stress test for rates, oil, and crowded AI positioning.

Samsung and SK Hynix Are 90.8% of Korean Semis: Where ETF Flow Is More Sensitive

A strategy note combining Korean semiconductor market-cap proxies and full ETF exposure data. The key is to separate absolute ETF ownership, market-cap-adjusted ETF sensitivity, and under-owned ETF gap candidates such as TCK, Daeduck Electronics, Korea Circuit and Doosan Tesna.

Korea's $350 Billion U.S. Investment Law: What Is the Nuclear Opportunity for Team Korea?

A framework for reading Korea's $350 billion U.S. strategic investment law through the nuclear value chain. The note separates nuclear beta in Doosan Enerbility, Hyundai E&C and KEPCO E&C from potential follow-on alpha in KEPCO KPS, Woori Technology, Woojin and power-equipment suppliers.

It Isn't Money Printed, It's Regulation Eased: Regulation-Adjusted Liquidity and Korean Financials

This is not a central-bank QE tape. It is a regulation-adjusted liquidity regime. We map U.S. dealer balance-sheet easing, Korea's WGBI / Value-up / capital-rule easing, and Japan's cash-to-market shift into one frame, and put Korean financials, U.S. market infrastructure and Japanese governance plays as the first-order winners.